Arrayit Corp
OTC:ARYC
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Arrayit Corp
OTC:ARYC
|
793.5 USD |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.3B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
147.9B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
36B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
274.9B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.2B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.8B USD |
Loading...
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
156.2B HKD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Arrayit Corp
Glance View
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. The company is headquartered in Sunnyvale, California. The company went IPO on 2001-05-25. The firm is engaged in discovery, development and manufacture of life science technologies and consumables for disease prevention, treatment and cure. The Company, through its technology, provides a line of products and services that serve the sequencing, genotyping, gene expression and protein analysis markets. The firm offers ArrayIt brand microarray products and services through a network of international life sciences and diagnostics distributors. Its offerings include Amplification and Labeling, Books and Software, Chemicals, Microarrayers, Microarray Scanners, Microarray Tools, Protein Microarrays, Microarray Substrates and Slides, and Microarray Printing. The company offers a line of diagnostics products, including cleanrooms, scanners, licensing, consumables and software.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Arrayit Corp’s Gross Margin has increased from 43.4% to 49.2%. During this period, it reached a low of 33.4% on Mar 31, 2014 and a high of 63.3% on Mar 31, 2015.
